Home > Clinical Resources > Guidance >
First published on 05 Apr 2018
Dear Liver Section members, I am writing to inform you of a significant caution about the use of ulipristal acetate (Esmya). Esmya is indicated for the pre-operative and intermittent treatment of moderate to severe symptoms of uterine fibroids in women […]
First published on 21 Feb 2018
Evidence-based recommendations on sofosbuvir–velpatasvir–voxilaprevir (Vosevi) for treating chronic hepatitis C in adults.
First published on 21 Nov 2017
Accreditation assessments for services in England, Wales, Northern Ireland and Scotland, including the independent sector are now conducted via https://www.thejag.org.uk
First published on 04 Apr 2017
The MHRA has recently circulated a Drug Safety Update regarding the risk of serious adverse events following the use of intravenous Hyoscine Butylbromide (Buscopan) in patients with underlying cardiac disease. Buscopan is commonly used during endoscopic procedures. It induces smooth […]
First published on 01 Feb 2017
An estimated 175,000 people have Lynch syndrome in the UK, however 95% of those do not know they have it. NICE recommends that microsatellite instability (MSI) testing or immunohistochemistry (IHC) should be used on all colorectal cancers, when first diagnosed, […]
First published on 04 Oct 2016
Following extensive discussion and a multi-stakeholder workshop with NHS England in late 2016 a set of principles has been agreed for a Rapid Colorectal Diagnostic Pathway following the introduction of a non-mandated Best Practice Tariff in England. The BSG recommends […]
First published on 01 Oct 2016
Helicobacter pylori in dyspepsia: test and treat – consultation and guidance documents from Public Health England. Guidance for primary care/ CCGs published October 2016. This guidance has been endorsed by members of the BSG Gastroduodenal Section. https://www.gov.uk/government/publications/helicobacter-pylori-diagnosis-and-treatment
First published on 01 Feb 2016
These recommendations were developed at a consensus meeting of clinicians and interested parties on 5 January 2016. Therapies that are NICE approved are presented in bold and those that are NICE unapproved are italicised. The prices of the different regimens […]
First published on 25 Nov 2015
NICE technology appraisal guidance [TA364] Published date: November 2015
First published on 25 Nov 2015